Am J Physiol Cell Physiol Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol (July 27, 2005). doi:10.1152/ajpcell.00126.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/6/C1522    most recent
00126.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azakie, A.
Right arrow Articles by He, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azakie, A.
Right arrow Articles by He, Y.
Submitted on March 21, 2005
Accepted on July 22, 2005

Divergent Transcriptional Enhancer Factor 1 (DTEF-1) regulates the cardiac Troponin T promoter

Anthony Azakie1*, Lauren LaMont1, Jeffrey R Fineman1, and Youping He1

1 Surgery and Pediatrics, University of California, San Francisco, San Francisco, CA, USA

* To whom correspondence should be addressed. E-mail: azakiet{at}surgery.ucsf.edu.

MCAT elements are essential for cardiac gene expression during development. Avian TEF-1 proteins are muscle-enriched and contribute to MCAT binding activities. However, direct activation of MCAT-driven promoters by TEF1-related proteins has not been uniformly achieved. DTEF-1 is a unique member of the TEF-1 multigene family with abundant transcripts in heart but not skeletal muscle. Here we show that DTEF-1 proteins are highly expressed in heart. Protein expression is activated at very early stages of chick embryogenesis (Hamburger- Hamilton HHstage 4, 16-18hours) after which DTEF-1 becomes abundant in the sinus venosus and is expressed at lower levels in the trabeculated, ventricular myocardium and ventricular outflow tracts. By chromatin immunoprecipitation, DTEF-1 interacts with the cTnT promoter in vivo. DTEF-1 also interacts with MEF 2 by co-immunoprecipitation and independently or co-operatively (with MEF 2) trans-activates the cTnT promoter. DTEF-1 isoforms do not activate the cTnT promoter in fibroblasts or skeletal muscle. DTEF-1 expression occurs very early in chick embryogenesis (16-18 hours), preceding sarcomeric protein expression, and it activates cardiac promoters. As such, DTEF-1 may be an early marker of the myocardial phenotype. DTEF-1 trans-activates the cTnT promoter in a tissue-specific fashion independent of AT-rich, MEF-2 or GATA sites. The observed spatial pattern suggests decreasing levels of expression from the cardiac inlet to the ventricular outflow tracts which may mark a cardiogenic or differentiation pathway that parallels the direction of flow through the developing chick heart.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Liu, D. Zhao, L. Qin, J. Li, and H. Zeng
Transcription Enhancer Factor 3 (TEF3) Mediates the Expression of Down Syndrome Candidate Region 1 Isoform 1 (DSCR1-1L) in Endothelial Cells
J. Biol. Chem., December 5, 2008; 283(49): 34159 - 34167.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Yoshida
MCAT Elements and the TEF-1 Family of Transcription Factors in Muscle Development and Disease
Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 8 - 17.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Azakie, J. R. Fineman, and Y. He
Myocardial transcription factors are modulated during pathologic cardiac hypertrophy in vivo
J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1262 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Azakie, J. R. Fineman, and Y. He
Sp3 inhibits Sp1-mediated activation of the cardiac troponin T promoter and is downregulated during pathological cardiac hypertrophy in vivo
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H600 - H611.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.